Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
Leticia Colyn, Marina Bárcena‐Varela, Gloria Álvarez‐Sola, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2380-2396
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

An Epigenetic Role of Mitochondria in Cancer
Yue Liu, Chao Chen, Xinye Wang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2518-2518
Open Access | Times Cited: 85
Exploiting RIG-I-like receptor pathway for cancer immunotherapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 69
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Daniel Oyón, Amaya López-Pascual, Borja Castelló-Uribe, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Diego F. Calvisi, Luke Boulter, Javier Vaquero, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 7, pp. 462-480
Open Access | Times Cited: 22
Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma
Salih Demir, Negin Razizadeh, Émilie Indersie, et al.
Hepatology Communications (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 8
EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
Alamelu Nachiyappan, Neelima Gupta, Reshma Taneja
FEBS Journal (2021) Vol. 289, Iss. 5, pp. 1329-1351
Closed Access | Times Cited: 47
Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
Alex Clavería-Cabello, José M. Herranz, M. Ujúe Latasa, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 4, pp. 989-1005
Open Access | Times Cited: 21
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 16
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma
Jasmin Elurbide, Leticia Colyn, M. Ujúe Latasa, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 116-127
Closed Access | Times Cited: 4
Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
María Arechederra, Miriam Recalde, María Gárate‐Rascón, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1265-1265
Open Access | Times Cited: 29
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming
Leticia Colyn, Gloria Álvarez‐Sola, M. Ujúe Latasa, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 19
Lenvatinib inhibited HCC cell migration and invasion through regulating the transcription and ubiquitination of UHRF1 and DNMT1
Ting Fang, Zhen Jiao, Yuting You, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115489-115489
Closed Access | Times Cited: 12
DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study
Junxiao Wang, Yaoqin Xue, Rui Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 11
Bioinformatics analysis of DNMT1 expression and its role in head and neck squamous cell carcinoma prognosis
Jili Cui, Zheng Lian, Yuanyuan Zhang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 26
G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications
Yuchao Ni, Mingchen Shi, Liangliang Liu, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2175-2175
Open Access | Times Cited: 3
Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
Dexter Kai Hao Thng, Lissa Hooi, Clarissa Chin Min Toh, et al.
Molecular Oncology (2023) Vol. 17, Iss. 11, pp. 2275-2294
Open Access | Times Cited: 8
Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer
Lei Sun, Ruonian Liu, Zong-Jian Wu, et al.
Gastroenterology (2023) Vol. 166, Iss. 3, pp. 466-482
Closed Access | Times Cited: 8
Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
Immacolata Maietta, Amparo Martínez, Rosana Álvarez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 824-824
Open Access | Times Cited: 13
G9a and DNMT1 inhibition modulates CDKN1A promoter methylation and the cell cycle leading to improvement in kidney fibrosis
Yuanyuan Yang, Zijian Zhou, Lujia Wang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130417-130417
Closed Access | Times Cited: 7
DNA methylation in cell plasticity and malignant transformation in liver diseases
Minwook Kim, Evan R. Delgado, Sungjin Ko
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108334-108334
Open Access | Times Cited: 11
The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling
Wenbo Ma, Jinqiang Zhang, Weina Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
The Role and Mechanism of the Histone Methyltransferase G9a in Tumors: Update
Hangsheng Zhou, Jiandong Gui, Lijie Zhu, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 449-462
Open Access | Times Cited: 1
STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A
Junsheng Chen, Da Wang, Guanhua Wu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Current and Emerging Approaches Targeting G9a for the Treatment of Various Diseases
Hua He, Xiaoxue Li, Feijing Su, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top